Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01587027 · ClinicalTrials.gov registry record · Phase 1
Safety Evaluation of Aminophylline and Methazolamide
A Phase 1 study, sponsored by Poudre Valley Health System.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT01587027 is a Phase 1 study that has completed, run by Poudre Valley Health System. The registered enrollment target is 16 participants.
The verdict
NCT01587027, a Phase 1 study, has completed, sponsored by Poudre Valley Health System.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
This safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide.
Interventions
- DRUG Methazolamide
- DRUG Aminophylline
- DRUG Aminophylline and Methazolamide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-12 |
| Est. Completion | 2012-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01587027
The ClinicalTrials.gov registry entry for NCT01587027 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Poudre Valley Health System, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Methazolamide is the first listed.
NCT01587027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01587027 about?
NCT01587027 is a clinical study titled "Safety Evaluation of Aminophylline and Methazolamide". This safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide.
What is the current status of trial NCT01587027?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2011-12. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01587027?
The interventions under investigation include: Methazolamide (DRUG), Aminophylline (DRUG), Aminophylline and Methazolamide (DRUG).
Who is sponsoring clinical trial NCT01587027?
This trial is sponsored by Poudre Valley Health System, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.